MENA Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2025-2033

MENA Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2025-2033

Report Format: PDF+Excel | Report ID: SR112024A16112
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   MENA Vaccine Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   MENA Vaccine Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   MENA Vaccine Market - Breakup by Product Type
    6.1    Multivalent Vaccine
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Forecast (2025-2033)
    6.2    Monovalent Vaccine
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Forecast (2025-2033)
7   MENA Vaccine Market - Breakup by Treatment Type
    7.1    Preventive Vaccine
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)
        7.1.3 Market Forecast (2025-2033)
    7.2    Therapeutic Vaccine
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024)
        7.2.3 Market Forecast (2025-2033)
8   MENA Vaccine Market - Breakup by Technology
    8.1    Conjugate Vaccines
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Forecast (2025-2033)
    8.2    Inactivated and Subunit Vaccines
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Forecast (2025-2033)
    8.3    Live Attenuated Vaccines
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2019-2024)
        8.3.3 Market Forecast (2025-2033)
    8.4    Recombinant Vaccines
        8.4.1 Overview
        8.4.2 Historical and Current Market Trends (2019-2024)
        8.4.3 Market Forecast (2025-2033)
    8.5    Toxoid Vaccines
        8.5.1 Overview
        8.5.2 Historical and Current Market Trends (2019-2024)
        8.5.3 Market Forecast (2025-2033)
    8.6    Others
        8.6.1 Historical and Current Market Trends (2019-2024)
        8.6.2 Market Forecast (2025-2033)
9   MENA Vaccine Market - Breakup by Route of Administration
    9.1    Intramuscular and Subcutaneous Administration
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2019-2024)
        9.1.3 Market Forecast (2025-2033)
    9.2    Oral Administration
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2019-2024)
        9.2.3 Market Forecast (2025-2033)
    9.3    Others
        9.3.1 Historical and Current Market Trends (2019-2024)
        9.3.2 Market Forecast (2025-2033)
10  MENA Vaccine Market - Breakup by Patient Type
    10.1    Pediatric
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2019-2024)
        10.1.3 Market Forecast (2025-2033)
    10.2    Adult
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2019-2024)
        10.2.3 Market Forecast (2025-2033)
11  MENA Vaccine Market - Breakup by Indication
    11.1    Bacterial Diseases
        11.1.1 Overview
        11.1.2 Historical and Current Market Trends (2019-2024)
        11.1.3 Market Segmentation
             11.1.3.1 Meningococcal Disease
             11.1.3.2 Pneumococcal Disease
             11.1.3.3 Diphtheria/Tetanus/Pertussis (DPT)
             11.1.3.4 Tuberculosis
             11.1.3.5 Haemophilus Influenzae (Hib)
             11.1.3.6 Typhoid
             11.1.3.7 Others
        11.1.4 Market Forecast (2025-2033)
    11.2    Viral Diseases
        11.2.1 Overview
        11.2.2 Historical and Current Market Trends (2019-2024)
        11.2.3 Market Segmentation
             11.2.3.1 Hepatitis
             11.2.3.2 Influenza
             11.2.3.3 Human Papillomavirus (HPV)
             11.2.3.4 Measles/Mumps/Rubella (MMR)
             11.2.3.5 Rotavirus
             11.2.3.6 Herpes Zoster
             11.2.3.7 Varicella
             11.2.3.8 Japanese Encephalitis
             11.2.3.9 Rubella
             11.2.3.10 Polio
             11.2.3.11 Rabies
             11.2.3.12 Dengue
             11.2.3.13 Others
        11.2.4 Market Forecast (2025-2033)
12  MENA Vaccine Market - Breakup by Distribution Channel
12.1    Hospital Pharmacies
        12.1.1 Overview
        12.1.2 Historical and Current Market Trends (2019-2024)
        12.1.3 Market Forecast (2025-2033)
    12.2    Retail Pharmacies
        12.2.1 Overview
        12.2.2 Historical and Current Market Trends (2019-2024)
        12.2.3 Market Forecast (2025-2033)
    12.3    Institutional Sale
        12.3.1 Overview
        12.3.2 Historical and Current Market Trends (2019-2024)
        12.3.3 Market Forecast (2025-2033)
    12.4    Others
        12.4.1 Overview
        12.4.2 Historical and Current Market Trends (2019-2024)
        12.4.3 Market Forecast (2025-2033)
13  MENA Vaccine Market - Breakup by End User
    13.1    Hospitals
        13.1.1 Overview
        13.1.2 Historical and Current Market Trends (2019-2024)
        13.1.3 Market Forecast (2025-2033)
    13.2    Clinics
        13.2.1 Overview
        13.2.2 Historical and Current Market Trends (2019-2024)
        13.2.3 Market Forecast (2025-2033)
    13.3    Vaccination Centers
        13.3.1 Overview
        13.3.2 Historical and Current Market Trends (2019-2024)
        13.3.3 Market Forecast (2025-2033)
    13.4    Academic and Research Institutes       
        13.4.1 Overview
        13.4.2 Historical and Current Market Trends (2019-2024)
        13.4.3 Market Forecast (2025-2033)
    13.5    Others
        13.5.1 Historical and Current Market Trends (2019-2024)
        13.5.2 Market Forecast (2025-2033)
14  MENA Vaccine Market – Breakup by Country
    14.1    Saudi Arabia
        14.1.1 Overview
        14.1.2 Historical and Current Market Trends (2019-2024)
        14.1.3 Market Breakup by Product Type
        14.1.4 Market Breakup by Treatment Type
        14.1.5 Market Breakup by Technology
        14.1.6 Market Breakup by Route of Administration
        14.1.7 Market Breakup by Patient Type
        14.1.8 Market Breakup by Indication
        14.1.9 Market Breakup by Distribution Channel
        14.1.10 Market Breakup by End User
        14.1.11 Key Players
        14.1.12 Market Forecast (2025-2033)
    14.2    Turkey
        14.2.1 Overview
        14.2.2 Historical and Current Market Trends (2019-2024)
        14.2.3 Market Breakup by Product Type
        14.2.4 Market Breakup by Treatment Type
        14.2.5 Market Breakup by Technology
        14.2.6 Market Breakup by Route of Administration
        14.2.7 Market Breakup by Patient Type
        14.2.8 Market Breakup by Indication
        14.2.9 Market Breakup by Distribution Channel
        14.2.10 Market Breakup by End User
        14.2.11 Key Players
        14.2.12 Market Forecast (2025-2033)
    14.3    Israel
        14.3.1 Overview
        14.3.2 Historical and Current Market Trends (2019-2024)
        14.3.3 Market Breakup by Product Type
        14.3.4 Market Breakup by Treatment Type
        14.3.5 Market Breakup by Technology
        14.3.6 Market Breakup by Route of Administration
        14.3.7 Market Breakup by Patient Type
        14.3.8 Market Breakup by Indication
        14.3.9 Market Breakup by Distribution Channel
        14.3.10 Market Breakup by End User
        14.3.11 Key Players
        14.3.12 Market Forecast (2025-2033)
    14.4    United Arab Emirates
        14.4.1 Overview
        14.4.2 Historical and Current Market Trends (2019-2024)
        14.4.3 Market Breakup by Product Type
        14.4.4 Market Breakup by Treatment Type
        14.4.5 Market Breakup by Technology
        14.4.6 Market Breakup by Route of Administration
        14.4.7 Market Breakup by Patient Type
        14.4.8 Market Breakup by Indication
        14.4.9 Market Breakup by Distribution Channel
        14.4.10 Market Breakup by End User
        14.4.11 Key Players
        14.4.12 Market Forecast (2025-2033)
    14.5    Egypt
        14.5.1 Overview
        14.5.2 Historical and Current Market Trends (2019-2024)
        14.5.3 Market Breakup by Product Type
        14.5.4 Market Breakup by Treatment Type
        14.5.5 Market Breakup by Technology
        14.5.6 Market Breakup by Route of Administration
        14.5.7 Market Breakup by Patient Type
        14.5.8 Market Breakup by Indication
        14.5.9 Market Breakup by Distribution Channel
        14.5.10 Market Breakup by End User
        14.5.11 Key Players
        14.5.12 Market Forecast (2025-2033)
    14.6    Iran
        14.6.1 Overview
        14.6.2 Historical and Current Market Trends (2019-2024)
        14.6.3 Market Breakup by Product Type
        14.6.4 Market Breakup by Treatment Type
        14.6.5 Market Breakup by Technology
        14.6.6 Market Breakup by Route of Administration
        14.6.7 Market Breakup by Patient Type
        14.6.8 Market Breakup by Indication
        14.6.9 Market Breakup by Distribution Channel
        14.6.10 Market Breakup by End User
        14.6.11 Key Players
        14.6.12 Market Forecast (2025-2033)
    14.7    Iraq
        14.7.1 Overview
        14.7.2 Historical and Current Market Trends (2019-2024)
        14.7.3 Market Breakup by Product Type
        14.7.4 Market Breakup by Treatment Type
        14.7.5 Market Breakup by Technology
        14.7.6 Market Breakup by Route of Administration
        14.7.7 Market Breakup by Patient Type
        14.7.8 Market Breakup by Indication
        14.7.9 Market Breakup by Distribution Channel
        14.7.10 Market Breakup by End User
        14.7.11 Key Players
        14.7.12 Market Forecast (2025-2033)
    14.8    Qatar
        14.8.1 Overview
        14.8.2 Historical and Current Market Trends (2019-2024)
        14.8.3 Market Breakup by Product Type
        14.8.4 Market Breakup by Treatment Type
        14.8.5 Market Breakup by Technology
        14.8.6 Market Breakup by Route of Administration
        14.8.7 Market Breakup by Patient Type
        14.8.8 Market Breakup by Indication
        14.8.9 Market Breakup by Distribution Channel
        14.8.10 Market Breakup by End User
        14.8.11 Key Players
        14.8.12 Market Forecast (2025-2033)
    14.9    Algeria
        14.9.1 Overview
        14.9.2 Historical and Current Market Trends (2019-2024)
        14.9.3 Market Breakup by Product Type
        14.9.4 Market Breakup by Treatment Type
        14.9.5 Market Breakup by Technology
        14.9.6 Market Breakup by Route of Administration
        14.9.7 Market Breakup by Patient Type
        14.9.8 Market Breakup by Indication
        14.9.9 Market Breakup by Distribution Channel
        14.9.10 Market Breakup by End User
        14.9.11 Key Players
        14.9.12 Market Forecast (2025-2033)
    14.10    Kuwait
        14.10.1 Overview
        14.10.2 Historical and Current Market Trends (2019-2024)
        14.10.3 Market Breakup by Product Type
        14.10.4 Market Breakup by Treatment Type
        14.10.5 Market Breakup by Technology
        14.10.6 Market Breakup by Route of Administration
        14.10.7 Market Breakup by Patient Type
        14.10.8 Market Breakup by Indication
        14.10.9 Market Breakup by Distribution Channel
        14.10.10 Market Breakup by End User
        14.10.11 Key Players
        14.10.12 Market Forecast (2025-2033)
    14.11    Morocco
        14.11.1 Overview
        14.11.2 Historical and Current Market Trends (2019-2024)
        14.11.3 Market Breakup by Product Type
        14.11.4 Market Breakup by Treatment Type
        14.11.5 Market Breakup by Technology
        14.11.6 Market Breakup by Route of Administration
        14.11.7 Market Breakup by Patient Type
        14.11.8 Market Breakup by Indication
        14.11.9 Market Breakup by Distribution Channel
        14.11.10 Market Breakup by End User
        14.11.11 Key Players
        14.11.12 Market Forecast (2025-2033)
    14.12    Oman
        14.12.1 Overview
        14.12.2 Historical and Current Market Trends (2019-2024)
        14.12.3 Market Breakup by Product Type
        14.12.4 Market Breakup by Treatment Type
        14.12.5 Market Breakup by Technology
        14.12.6 Market Breakup by Route of Administration
        14.12.7 Market Breakup by Patient Type
        14.12.8 Market Breakup by Indication
        14.12.9 Market Breakup by Distribution Channel
        14.12.10 Market Breakup by End User
        14.12.11 Key Players
        14.12.12 Market Forecast (2025-2033)
    14.13    Others
        14.13.1 Historical and Current Market Trends (2019-2024)
        14.13.2 Market Forecast (2025-2033)
15  MENA Vaccine Market – Competitive Landscape
    15.1    Overview
    15.2    Market Structure
    15.3    Market Player Positioning
    15.4    Top Winning Strategies
    15.5    Competitive Dashboard
    15.6    Company Evaluation Quadrant
16  Profiles of Key Players
    16.1    Company A 
        16.1.1 Business Overview
        16.1.2 Product Portfolio
        16.1.3 Business Strategies
        16.1.4 SWOT Analysis
        16.1.5 Major News and Events
    16.2    Company B
        16.2.1 Business Overview
        16.2.2 Product Portfolio
        16.2.3 Business Strategies
        16.2.4 SWOT Analysis
        16.2.5 Major News and Events
    16.3    Company C
        16.3.1 Business Overview
        16.3.2 Product Portfolio
        16.3.3 Business Strategies
        16.3.4 SWOT Analysis
        16.3.5 Major News and Events
    16.4    Company D 
        16.4.1 Business Overview
        16.4.2 Product Portfolio
        16.4.3 Business Strategies
        16.4.4 SWOT Analysis
        16.4.5 Major News and Events
    16.5    Company E
        16.5.1 Business Overview
        16.5.2 Product Portfolio
        16.5.3 Business Strategies
        16.5.4 SWOT Analysis
        16.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

17  MENA Vaccine Market - Industry Analysis
    17.1    Drivers, Restraints, and Opportunities
        17.1.1 Overview
        17.1.2 Drivers
        17.1.3 Restraints
        17.1.4 Opportunities
    17.2   Porters Five Forces Analysis
        17.2.1 Overview
        17.2.2 Bargaining Power of Buyers
        17.2.3 Bargaining Power of Suppliers
        17.2.4 Degree of Competition
        17.2.5 Threat of New Entrants
        17.2.6 Threat of Substitutes
    17.3    Value Chain Analysis
18  Appendix

MENA Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Country 2025-2033
Purchase Options Year End sale




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More
Gulf Excellent Group

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Read More
FS Corporation Inc.

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

Read More
Egyptian Industrial Investment Group

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

Read More
Vishnu Chemicals

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

Read More
MOUNT EVEREST BREWERIES LIMITED

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

Read More
Borges Branded Foods

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

Read More
Godrej Consumer Products Limited

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

Read More
ADC Therapeutics

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

Read More
Ivanti

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

Read More
Asiatic Electrical & Switchgear P. Ltd.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Read More
Denka Co., Ltd.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.

Read More